Media formats available:
Recommended
- LDL-c: Done Deal, Next Epigenetics?Understanding epigenetics: The potential rationale for BET inhibition in management of CVD
Jorge Plutzky, MD
- LDL-c: Done Deal, Next Epigenetics?A clinical view on BET inhibition in targeting residual risk in CVD and diabetes
Prof Kausik Ray